Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Advanced Container Technologies Inc. (ACTX) Message Board

420 with CNW — Israeli Researcher Behind THC’s

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 527
(Total Views: 222)
Posted On: 04/05/2023 5:35:39 PM
Avatar
Posted By: NetworkNewsWire
420 with CNW — Israeli Researcher Behind THC’s Discovery Dies at Age 92

Raphael Mechoulam, an Israeli scientist whose work advanced knowledge of marijuana and the chemical elements responsible for the drug’s distinct high, has passed away. The 92-year-old Mechoulam passed away in Jerusalem last month. One of Mechoulam’s major contributions to cannabis studies was the discovery of the psychoactive component of the marijuana plant: THC. He was given the moniker “Father of Marijuana Research” for his contributions.

Asher Cohen, president of the Hebrew University of Jerusalem, described Mechoulam as a charismatic and brilliant pioneer. Mechoulam was a longtime faculty member at the university.

“Prof. Mechoulam is responsible for amassing the majority of scientific and human cannabis knowledge. He laid the foundation for ground-breaking research and instigated international scientific collaboration,” said Cohen. “The academic community, as well as the university, is in mourning today.”

Mechoulam was born in Bulgaria in 1930, and then moved to Israel in 1949 where he started studying chemistry. When Mechoulam joined the cannabis research field in the 1960s, cocaine and morphine had long been isolated from coca and opium, the plants in which the elements occur naturally. But it was not the same case for cannabis, which inhibited academic research on the drug in pharmacology or chemistry labs.

As a result, in 1962, Mechoulam and his research group at the Weizmann Institute of Science in Israel, where they were working at the time, began to concentrate on the drug just as it was about to experience a worldwide upsurge in popularity.

Throughout Mechoulam’s career, cannabis gained both popularity and notoriety as arguments over the drug’s safety grew. In 1970, the drug was classified as a controlled substance in the United States.

Mechoulam worked to synthesize and isolate other elements found in the cannabis plant as well as demonstrate its potential for use in medicine, including the treatment of autoimmune disorders and epilepsy. His work contributed to demonstrating that, despite the debate surrounding its use in the latter half of the 20th century, people have been using marijuana for hundreds of years. For example, he and his group conducted research on the ashes of a young woman who had passed away giving birth in a fourth-century Roman tomb, and they then published their findings in the “Nature” journal in 1993.

“They undoubtedly gave her something to numb the pain or treat the apparent hemorrhage that she was experiencing. We suspected it might be marijuana,” he said in an interview with NPR that year. His suspicions turned out to be accurate, and an analysis produced the first physical proof of cannabis use in the historic Middle East.

The death of this pioneering scientist has robbed the world of a brilliant thinker upon whose work present-day marijuana companies and even ancillary ones such as Advanced Container Technologies Inc. (OTC: ACTX) are benefiting directly or indirectly.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer




(0)
(0)




Advanced Container Technologies Inc. (ACTX) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us